Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

A man has been charged after a protestor scaled Big Ben and clung to the London landmark for 16 hours in a stand off. Daniel Day, 29, of Palmerston Road, Westcliff-on-Sea, Essex has been charged ...

Chang later returned home on the same road where hours earlier he’d hit Lilly Glaubach. He spent one more night with his wife and daughter before police knocked on his door after a Good ...

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks. Lone Pine Capital, established in 1997 by Stephen Mandel, is a leading hedge ...

The "Nosferatu" star's dress is based on a 1995 runway look. Lily-Rose Depp channeled the gothic vibe of her "Nosferatu" character, Ellen Hutter, in a black lace dress on the Oscars red carpet on ...

Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...

Credit: shisu_ka/Shutterstock. Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise oncology molecular glue therapeutics. The ...

When you walk in the door and kick off your shoes, does it actually hurt the health of your feet to walk around barefoot on hard floors? It’s not the most comfortable feeling, but doctors say ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.